BB Biotech AG (XSWX:BION) FCF Margin %: -2,193.24% (As of Mar. 2026)


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG FCF Margin %?

BB Biotech AG XSWX:BION +2.14% 33 FCF Margin % is -2,193.24% as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, BB Biotech AG ranks better than 96.35% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BB Biotech AG's Free Cash Flow for the three months ended in Mar. 2026 was CHF373.7 Mil. BB Biotech AG's Revenue for the three months ended in Mar. 2026 was CHF-17.0 Mil. Therefore, BB Biotech AG's FCF Margin % for the quarter that ended in Mar. 2026 was -2,193.24%.

As of today, BB Biotech AG's current FCF Yield % is 14.93%.

The historical rank and industry rank for BB Biotech AG's FCF Margin % or its related term are showing as below:

XSWX:BION' s FCF Margin % Range Over the Past 10 Years
Min: -109.37   Med: 27.65   Max: 369.99
Current: 48.1


During the past 13 years, the highest FCF Margin % of BB Biotech AG was 369.99%. The lowest was -109.37%. And the median was 27.65%.

XSWX:BION's FCF Margin % is ranked better than
96.35% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs XSWX:BION: 48.10


BB Biotech AG FCF Margin % Related Terms


BB Biotech AG FCF Margin % Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG FCF Margin % Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.92 -65.81 -109.37 369.99 52.66

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.99 63.98 14.04 3.40 -2,193.24

XSWX:BION vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, BB Biotech AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's FCF Margin % falls into.


XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BB Biotech AG's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=309.145/587.007
=52.66 %

BB Biotech AG's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=373.707/-17.039
=-2,193.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -2,193.24% mean?
BB Biotech AG (XSWX:BION) has a FCF Margin % of -2,193.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #35 out of 960 companies in the Biotechnology industry, placing it in the top 3.6%.
Is BB Biotech AG's FCF Margin % too high?
BB Biotech AG's current FCF Margin % is -2,193.24%. Based on the distribution chart, BB Biotech AG ranks #35 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #35 out of 960 companies for FCF Margin %. This places BB Biotech AG in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current FCF Margin % is -2,193.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current FCF Margin % of -2,193.24%. The current FCF Margin % is -2,193.24%. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current FCF Margin % is -2,193.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price